{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:30:03Z","timestamp":1793806203645,"version":"4.6.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Cardiovascular disease remains a major global public health burden. In recent years, advances in cardiac imaging and molecular genetics have renewed clinical attention to the diagnosis, treatment, and prevention of cardiomyopathies. However, a comprehensive quantitative assessment of the overall mortality burden associated with cardiomyopathy (CM) remains limited. To address this gap, we analyzed trends and disparities in CM-related mortality in the United States between 1999 and 2023, drawing on data from the Centers for Disease Control and Prevention (CDC WONDER) database. This was a population-based retrospective observational study using U.S. national mortality data from CDC WONDER. Deaths among individuals aged\u2005\u2265\u200525 years were identified using ICD-10 code I42 listed as the underlying cause of death. Crude and age-adjusted mortality rates (AAMRs) were computed using the 2000 U.S. standard population, and age-specific mortality rates were used for predefined age-group analyses. Joinpoint regression analysis (version 5.1.0.0) was used to estimate annual percent changes (APCs) and average annual percent changes (AAPCs), with statistical significance set at\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05. From 1999 to 2023, 576,693 CM-related deaths were recorded among U.S. adults aged\u2005\u2265\u200525 years. The AAMR declined from 15.14 to 7.11 per 100,000 population. Joinpoint regression identified no statistically significant joinpoints, with an APC and AAPC of \u22123.21% (95% CI: \u22123.34 to \u22123.08;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001) over the entire study period. Mortality remained higher among men and non-Hispanic Black individuals, and geographic heterogeneity persisted, with higher burdens observed in the Midwest and South. Age-specific mortality rates declined overall across all predefined age groups but remained highest among adults aged\u2005\u2265\u200585 years. In the urbanization-specific analysis limited to 1999 to 2020, AAMRs were higher in metropolitan counties at baseline, whereas a modest nonmetropolitan excess had emerged by 2020. Cardiomyopathy-related mortality in the United States declined substantially between 1999 and 2023, although important population-level disparities remained by sex, race\/ethnicity, region, and age. Urban\u2013rural disparities evolved during 1999 to 2020, with mortality initially higher in metropolitan counties and a modest nonmetropolitan excess emerging by 2020. Because this study used aggregated mortality data, these findings should be interpreted as national population-level patterns rather than individual-level risks, prognostic differences, or causal effects.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050903","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:00:52Z","timestamp":1790359252000},"page":"e50903","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cardiomyopathy-related mortality in the United States, 1999 to 2023"],"prefix":"10.1097","volume":"105","author":[{"given":"Hui","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou, China"},{"name":"Department of Cardiology, Guizhou Provincial Key Laboratory of Pathogenesis and Prevention of Common Chronic Diseases, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2987-0491","authenticated-orcid":false,"given":"Yu","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawang","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou, China"},{"name":"Department of Cardiology, Guizhou Provincial Key Laboratory of Pathogenesis and Prevention of Common Chronic Diseases, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongzhuang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou, China"},{"name":"Department of Cardiology, Guizhou Provincial Key Laboratory of Pathogenesis and Prevention of Common Chronic Diseases, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengying","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Electrocardiography, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4926-1706","authenticated-orcid":false,"given":"Youfu","family":"He","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou, China"},{"name":"Department of Cardiology, Guizhou Provincial Key Laboratory of Pathogenesis and Prevention of Common Chronic Diseases, Guiyang, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies.","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2796.1992.tb00623.x","article-title":"The prevalence of hypertrophic cardiomyopathy in men: an echocardiographic population screening study with a review of death records.","volume":"232","author":"Agnarsson","year":"1992","journal-title":"J Intern Med"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jacc.2007.10.055","article-title":"Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.","volume":"51","author":"Basavarajaiah","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture.","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.111.055673","article-title":"Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening.","volume":"125","author":"Migliore","year":"2012","journal-title":"Circulation"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"e009292","DOI":"10.1161\/CIRCHEARTFAILURE.121.009292","article-title":"Demographic and regional trends of hypertrophic cardiomyopathy-related mortality in the United States, 1999 to 2019.","volume":"15","author":"Minhas","year":"2022","journal-title":"Circ Heart Fail"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"108119","DOI":"10.1016\/j.amepre.2025.108119","article-title":"Trends in mortality rates for cardiovascular disease subtypes among adults, 2010\u20132023.","volume":"70","author":"Woodruff","year":"2026","journal-title":"Am J Prev Med"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"295","DOI":"10.14740\/cr2071","article-title":"Prevalence and incidence of dilated cardiomyopathy in the United States and Western Europe: a systematic review.","volume":"16","author":"Myers","year":"2025","journal-title":"Cardiol Res"},{"key":"R10-20261104","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R12-20261104","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies.","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R13-20261104","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/ejhf.1914","article-title":"Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy.","volume":"22","author":"Merlo","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R14-20261104","doi-asserted-by":"crossref","first-page":"769138","DOI":"10.3389\/fcvm.2021.769138","article-title":"Angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers: anti-arrhythmic drug for arrhythmogenic right ventricular cardiomyopathy.","volume":"8","author":"Tu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R15-20261104","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines.","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"R16-20261104","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacep.2021.06.006","article-title":"Trends in cardiovascular implantable electronic device insertion between 1988 and 2018 in Olmsted County.","volume":"8","author":"Vaidya","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"R17-20261104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/europace\/euad059","article-title":"Timing of cardiac resynchronization therapy implantation.","volume":"25","author":"Leyva","year":"2023","journal-title":"Europace"},{"key":"R18-20261104","doi-asserted-by":"crossref","first-page":"e2326346","DOI":"10.1001\/jamanetworkopen.2023.26346","article-title":"Trends in alcohol-related deaths by sex in the US, 1999\u20132020.","volume":"6","author":"Karaye","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R19-20261104","first-page":"8","article-title":"Gender bias in cardiovascular disease prevention, detection, and management, with specific reference to coronary artery disease.","volume":"12","author":"Desai","year":"2021","journal-title":"J Midlife Health"},{"key":"R20-20261104","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11897-021-00526-x","article-title":"Sex differences in hypertrophic cardiomyopathy: interaction with genetics and environment.","volume":"18","author":"Butters","year":"2021","journal-title":"Curr Heart Fail Rep"},{"key":"R21-20261104","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1751-7176.2008.07918.x","article-title":"Cardiovascular disease in blacks: can we stop the clock?","volume":"10","author":"Ferdinand","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R22-20261104","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/jwh.2019.8125","article-title":"The cardiovascular disease epidemic in African American women: recognizing and tackling a persistent problem.","volume":"29","author":"Ebong","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"key":"R23-20261104","doi-asserted-by":"crossref","first-page":"e031484","DOI":"10.1161\/JAHA.123.031484","article-title":"Trends and disparities in cardiovascular death in sarcoidosis: a population-based retrospective study in the United States from 1999 to 2020.","volume":"13","author":"Tan","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R24-20261104","doi-asserted-by":"crossref","first-page":"e039031","DOI":"10.1161\/JAHA.124.039031","article-title":"Impact of social determinants of health on cardiovascular disease.","volume":"14","author":"Bazoukis","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"R25-20261104","first-page":"e80442","article-title":"Navigating the future of elderly healthcare: a comprehensive analysis of aging populations and mortality trends using National Inpatient Sample (NIS) data (2010\u20132024).","volume":"17","author":"Shreya","year":"2025","journal-title":"Cureus"},{"key":"R26-20261104","first-page":"100336","article-title":"The mortality trends of falls among the elderly adults in the mainland of China, 2013\u20132020: a population-based study through the National Disease Surveillance Points system.","volume":"19","author":"Zhang","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"R27-20261104","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people.","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"R28-20261104","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cjco.2023.01.002","article-title":"Use of guideline-directed medical therapy in patients aged 80 years or older with heart failure with reduced ejection fraction.","volume":"5","author":"Barry","year":"2023","journal-title":"CJC Open"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:02:16Z","timestamp":1793804536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050903"}},"subtitle":["A national population-based observational study"],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":26,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050903","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"2025-12-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}